[In vitro study on the validity of the use of antimycograms in the target treatment of superficial candidiasis].
Pezzarossa
E
E
Bossano
A
A
Cervetti
O
O
Forte
M
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D000935:Antifungal Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002175:Candida / Q000187:drug effects*; D002179:Candidiasis, Cutaneous / Q000188:drug therapy*; D002648:Child; D000077768:Ciclopirox; D003022:Clotrimazole / Q000494:pharmacology; D004464:Econazole / Q000494:pharmacology; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology; D008297:Male; D008825:Miconazole / Q000031:analogs & derivatives / Q000494:pharmacology; D008875:Middle Aged; D009761:Nystatin / Q000494:pharmacology; D011728:Pyridones / Q000494:pharmacology
D000935:Antifungal Agents; D007093:Imidazoles; D011728:Pyridones; D009761:Nystatin; D000077768:Ciclopirox; D004464:Econazole; D008825:Miconazole; D003022:Clotrimazole; C020382:isoconazole; C020527:tioconazole
Studio "in vitro" sulla validità dell'utilizzazione dell'antimicogramma nel trattamento mirato delle candidosi superficiali.